The Rett Syndrome market is witnessing significant advances driven by innovative therapies and growing awareness among healthcare providers and patients. This niche market is characterized by rapid development of gene therapies and novel compounds that address the underlying causes of the disorder. As the industry size expands, the market dynamics show promising opportunities anchored in...